6/30/26
ELEVANCE HEALTH (ANTM)
Thesis: Elevance Health: the story is balanced — Medical Loss Ratio (MLR) performance versus guidance - every 10-20 basis point variance materially impacts earnings
What Moves the Stock
- 1Medical Loss Ratio (MLR) performance versus guidance - every 10-20 basis point variance materially impacts earnings
- 2Medicare Advantage membership growth and Star Ratings (4+ stars unlock quality bonuses worth $1,000+ per member annually)
- 3Medicaid redetermination impacts following pandemic-era continuous enrollment unwinding (completed by mid-2024, affecting 15M+ members industry-wide)
- 4Government reimbursement rate changes - CMS Medicare Advantage rate updates (typically announced in April) and state Medicaid rate adequacy
- 5Carelon revenue growth and margin expansion as the services business scales with external clients
- 6Commercial & Specialty Business (employer-sponsored plans, individual ACA marketplace) - approximately 40% of premium revenue
- 7Government Business (Medicare Advantage, Medicaid managed care) - approximately 60% of premium revenue
- 8Carelon Health Services (PBM, specialty pharmacy, behavioral health, care management) - estimated $40B+ annual revenue
My Notes
- value - Trades at 0.4x P/S and 1.7x P/B, below historical averages and peers, attracting value investors seeking healthcare exposure…
- Rising rates modestly benefit investment income on $30B+ investment portfolio (primarily fixed-income securities backing claim reserves)…
- Watch on earnings: Monthly medical membership enrollment trends by segment (commercial, Medicare Advantage, Medicaid) from company investor updates, CMS Medicare Advantage benchmark rate announcements (typically April) and Star Ratings (October) affecting 2027 revenue, Medical cost trend indicators: hospital admission rates, emergency room utilization, specialty drug spending per member.
One Sentence Summary:
Elevance Health: the story is balanced — medical loss ratio (mlr) performance versus guidance - every 10-20 basis point variance materially impacts earnings.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.